SynthesisVirology2022

Krebs von den Lungen-6 (KL-6) as a clinical marker for severe COVID-19: A systematic review and meta-analyses.

Nadereh Naderi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.